AeroLeads people directory · profile
Hari Kumar Email & Phone Number
Member of the External Board
at
UCL Global Business School for Health
1 work email found
@ucl.ac.uk
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Member of the External Board
Location
Basel, Basel, Switzerland
Company size
Who is Hari Kumar? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Hari Kumar is listed as Member of the External Board at UCL Global Business School for Health, a company with 73 employees, based in Basel, Basel, Switzerland. AeroLeads shows a work email signal at ucl.ac.uk and a matched LinkedIn profile for Hari Kumar.
Hari Kumar previously worked as Chairman Of The Board at Kinarus Therapeutics Ag and Member of Board of Directors at Panmira Pharmaceuticals Llc. Hari Kumar holds Phd, Immunology from University Of London.
Company email context
Email format at UCL Global Business School for Health
This section adds company-level context without repeating Hari Kumar's masked contact details.
{first_initial}{last}@ucl.ac.uk
79% confidence
AeroLeads found 1 current-domain work email signal for Hari Kumar. Compare company email patterns before reaching out.
Profile bio
About Hari Kumar
Hari Kumar is a Member of the External Board at UCL Global Business School for Health. He possess expertise in pharmaceutical industry, management, leadership, drug discovery, biotechnology and 15 more skills.
Listed skills include Pharmaceutical Industry, Management, Leadership, Drug Discovery, and 16 others.
Current workplace
Hari Kumar's current company
Company context helps verify the profile and gives searchers a useful next step.
Ucl Global Business School For Health
16 roles · 38 years
Hari Kumar work experience
A career timeline built from the work history available for this profile.
Member Of The External Board
Current
Sep 2021 - Present
Chairman Of The Board
Current
Kinarus Therapeutics Ag
Kinarus AG is a Swiss biotechnology company that has a phase 2 clinical stage asset (KIN001) being developed in the treatment of Covid19. KIN001 is unique in that it is not only anti-viral, but also has direct anti-inflammatory and anti-fibrotic properties. This potentially makes it a First-in-Class oral treatment for Covid19.
Jun 2022 - Present
Member Of Board Of Directors
Current
Panmira Pharmaceuticals Llc
Jun 2013 - Present
Chief Executive Officer
Panmira Pharmaceuticals Llc
Oct 2011 - Jun 2013
Chief Business Officer
Panmira Pharmaceuticals Llc
Panmira Pharmaceuticals is a spinout from Amira Pharmaceuticals which was acquired by Bristol Myers-Squibb Inc. Panmira will focus on managing the assets that were spun out of Amira.
Sep 2011 - Oct 2011
Board Member
Feb 2020 - Feb 2022
Member Board Of Directors
Biovie Inc. ; Bullet Biotechnology, Inc.
May 2017 - Mar 2021
Consultant
Transitioning Adheron to Roche and helping the asset, SDP 051 move along the development path.
Oct 2015 - Apr 2017
Member Of Board Of Directors
Cymabay Therapeutics
Jun 2012 - Jun 2016
Ceo And Board Member
Adheron Therapeutics (formerly known as Synovex Corporation) is a biotechnology company that is focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases. Roche acquires Adheron for $580M in October 2015
Jul 2013 - Oct 2015
Chief Business Officer
Oct 2007 - Sep 2011
Global Business Development Director
Jul 2003 - Dec 2006
Global Lifecycle Leader, Transplantation
Nov 1999 - Jul 2003
European Marketing Director
Eisai Ltd
1996 - 1999
~3 yrs
Business Unit Manager
Roche Products Ltd.
1988 - 1996
~8 yrs
2 education records
Hari Kumar education
Phd, Immunology
Bsc (Hons), Biochemistry
Unversity Of Malaya
FAQ
Frequently asked questions about Hari Kumar
Quick answers generated from the profile data available on this page.
What company does Hari Kumar work for?
Hari Kumar works for UCL Global Business School for Health.
What is Hari Kumar's role at UCL Global Business School for Health?
Hari Kumar is listed as Member of the External Board at UCL Global Business School for Health.
What is Hari Kumar's email address?
AeroLeads has found 1 work email signal at @ucl.ac.uk for Hari Kumar at UCL Global Business School for Health.
Where is Hari Kumar based?
Hari Kumar is based in Basel, Basel, Switzerland while working with UCL Global Business School for Health.
What companies has Hari Kumar worked for?
Hari Kumar has worked for Ucl Global Business School For Health, Kinarus Therapeutics Ag, Panmira Pharmaceuticals Llc, Trio - Translational Research In Oncology, and Biovie Inc. ; Bullet Biotechnology, Inc..
How can I contact Hari Kumar?
You can use AeroLeads to view verified contact signals for Hari Kumar at UCL Global Business School for Health, including work email, phone, and LinkedIn data when available.
What schools did Hari Kumar attend?
Hari Kumar holds Phd, Immunology from University Of London.
What skills is Hari Kumar known for?
Hari Kumar is listed with skills including Pharmaceutical Industry, Management, Leadership, Drug Discovery, Biotechnology, Clinical Development, Lifesciences, and Drug Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Hari Kumar you were looking for.
View similar profiles
